Aparna Pal

1.0k total citations
32 papers, 557 citations indexed

About

Aparna Pal is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Aparna Pal has authored 32 papers receiving a total of 557 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Endocrinology, Diabetes and Metabolism, 13 papers in Surgery and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Aparna Pal's work include Pituitary Gland Disorders and Treatments (21 papers), Adrenal and Paraganglionic Tumors (9 papers) and Growth Hormone and Insulin-like Growth Factors (8 papers). Aparna Pal is often cited by papers focused on Pituitary Gland Disorders and Treatments (21 papers), Adrenal and Paraganglionic Tumors (9 papers) and Growth Hormone and Insulin-like Growth Factors (8 papers). Aparna Pal collaborates with scholars based in United Kingdom, Sri Lanka and Italy. Aparna Pal's co-authors include Mark I. McCarthy, Anna L. Gloyn, Fredrik Karpe, Simon Cudlip, John Wass, Thomas M. Barber, Nicola Cooper, Simon A. Rudge, Martijn van de Bunt and Katherine Lachlan and has published in prestigious journals such as New England Journal of Medicine, The Lancet and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Aparna Pal

29 papers receiving 549 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aparna Pal United Kingdom 11 283 218 162 82 67 32 557
Andreas Moraitis United States 14 309 1.1× 143 0.7× 228 1.4× 61 0.7× 56 0.8× 41 565
Susana Igreja United Kingdom 10 418 1.5× 274 1.3× 187 1.2× 155 1.9× 39 0.6× 14 724
Tingwei Su China 15 322 1.1× 135 0.6× 270 1.7× 102 1.2× 33 0.5× 52 659
Péter Gergics Hungary 14 257 0.9× 209 1.0× 90 0.6× 54 0.7× 134 2.0× 29 501
Antoine Martinez France 10 249 0.9× 185 0.8× 227 1.4× 19 0.2× 95 1.4× 10 513
H. Rosemarie Davidson United Kingdom 6 367 1.3× 304 1.4× 95 0.6× 112 1.4× 219 3.3× 6 798
Eva Szarek United States 13 208 0.7× 172 0.8× 215 1.3× 38 0.5× 65 1.0× 22 515
Esther Díaz‐Rodriguez Spain 12 165 0.6× 160 0.7× 110 0.7× 44 0.5× 18 0.3× 14 446
Marie Batisse‐Lignier France 15 373 1.3× 223 1.0× 312 1.9× 28 0.3× 109 1.6× 27 667
George Jeha United States 12 225 0.8× 187 0.9× 179 1.1× 36 0.4× 256 3.8× 23 551

Countries citing papers authored by Aparna Pal

Since Specialization
Citations

This map shows the geographic impact of Aparna Pal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aparna Pal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aparna Pal more than expected).

Fields of papers citing papers by Aparna Pal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aparna Pal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aparna Pal. The network helps show where Aparna Pal may publish in the future.

Co-authorship network of co-authors of Aparna Pal

This figure shows the co-authorship network connecting the top 25 collaborators of Aparna Pal. A scholar is included among the top collaborators of Aparna Pal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aparna Pal. Aparna Pal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pofi, Riccardo, John Ayuk, John Wass, et al.. (2025). Venous thromboembolism in patients with pituitary adenoma: UK multicentre cohort study. European Journal of Endocrinology. 193(2). 270–277.
2.
Urwyler, Sandrine, Kirstie Lithgow, Karin Bradley, et al.. (2024). Efficacy of cabergoline in non-irradiated patients with acromegaly: a multi-centre cohort study. European Journal of Endocrinology. 190(1). 113–120. 5 indexed citations
3.
Pofi, Riccardo, Tim James, Brian Shine, et al.. (2024). Copeptin and the syndrome of inappropriate antidiuresis (SIAD) after pituitary transsphenoidal surgery. Endocrinology Diabetes & Metabolism. 7(1). e467–e467.
4.
Löo, H., Tim James, Brian Keevil, et al.. (2024). Development of diagnostic algorithm for Cushing’s syndrome: a tertiary centre experience. Journal of Endocrinological Investigation. 47(10). 2449–2459. 4 indexed citations
5.
Pal, Aparna, et al.. (2024). Lennox- Gastaut Syndrome (Childhood Epileptic Encephalopathy) – A Rare Case Report. International Journal of Nursing Education and Research. 212–214.
6.
Pofi, Riccardo, et al.. (2023). “A morning cortisol is the most effective clinical predictor of short synacthen test outcome”: A tertiary care centre experience. Clinical Endocrinology. 99(2). 142–151. 5 indexed citations
7.
Earls, Peter, Adam C. Wilkinson, Monika Hofer, et al.. (2023). Predictors of pituitary tumour behaviour: an analysis from long-term follow-up in 2 tertiary centres. European Journal of Endocrinology. 189(1). 106–114. 8 indexed citations
8.
Levy, Miles, Aparna Pal, William M Drake, et al.. (2023). A study of acromegaly-associated headache with somatostatin analgesia. Endocrine Related Cancer. 30(3). 6 indexed citations
9.
Atila, Cihan, Aoife Garrahy, Bettina Winzeler, et al.. (2022). Central diabetes insipidus from a patient's perspective: management, psychological co-morbidities, and renaming of the condition: results from an international web-based survey. The Lancet Diabetes & Endocrinology. 10(10). 700–709. 37 indexed citations
10.
Garrahy, Aoife, Jeremy Tomlinson, & Aparna Pal. (2022). Glucocorticoid induced adrenal insufficiency. BMJ. 379. e065137–e065137. 5 indexed citations
11.
Jafar‐Mohammadi, Bahram, Anouk Borg, Jane Halliday, et al.. (2022). Post-pituitary surgery copeptin analysis as a ‘rule-out’ test for post-operative diabetes insipidus. Endocrine. 79(2). 358–364. 10 indexed citations
12.
13.
Woodrow, Charles J., et al.. (2020). Delayed diagnosis of T3 supplementation in a bodybuilder presenting with tachycardia and features of sepsis. BMJ Case Reports. 13(1). e232867–e232867. 4 indexed citations
14.
Pal, Aparna, Laurence Leaver, & John Wass. (2019). Pituitary adenomas. BMJ. 365. l2091–l2091. 15 indexed citations
15.
Khan, Shoaib, et al.. (2019). Plurihormonal Pit-1 lineage adenoma presenting as meningitis with recurrence after somatostatin analogue. Endocrinology Diabetes and Metabolism Case Reports. 2019. 3 indexed citations
16.
Angelousi, Anna, Karina Danilowicz, Marina Tsoli, et al.. (2018). Clinical, Endocrine and Imaging Characteristics of Patients with Primary Hypophysitis. Hormone and Metabolic Research. 50(4). 296–302. 27 indexed citations
17.
Pal, Aparna, Thomas M. Barber, Martijn van de Bunt, et al.. (2012). PTEN Mutations as a Cause of Constitutive Insulin Sensitivity and Obesity. New England Journal of Medicine. 367(11). 1002–1011. 174 indexed citations
18.
Pal, Aparna & Mark I. McCarthy. (2012). The genetics of type 2 diabetes and its clinical relevance. Clinical Genetics. 83(4). 297–306. 39 indexed citations
19.
Pal, Aparna, Patricia Díaz Guardiola, James V. Byrne, et al.. (2011). Pituitary apoplexy in non‐functioning pituitary adenomas: long term follow up is important because of significant numbers of tumour recurrences. Clinical Endocrinology. 75(4). 501–504. 47 indexed citations
20.
Pal, Aparna, et al.. (2010). Recurrence rates in patients with non-functioning pituitary adenomas presenting with acute apoplexy: a long-term follow-up study. 21. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andreas Moraitis Breakdown of academic impact, for papers by Susana Igreja Breakdown of academic impact, for papers by Tingwei Su Breakdown of academic impact, for papers by Péter Gergics Breakdown of academic impact, for papers by Antoine Martinez Breakdown of academic impact, for papers by H. Rosemarie Davidson Breakdown of academic impact, for papers by Eva Szarek Breakdown of academic impact, for papers by Esther Díaz‐Rodriguez Breakdown of academic impact, for papers by Marie Batisse‐Lignier Breakdown of academic impact, for papers by George Jeha
Rankless by CCL
2026